Legend Biotech Corp - ADR

Legend Biotech Corp - ADR

LEGN - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$4B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Legend Biotech Corp - ADRLegend Biotech Corp - ADR-43.3--7%3.50.2
$56.89

Target Price by Analysts

169.6% upsideLegend Biotech Target Price DetailsTarget Price

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$4.00 Billion
Enterprise Value$3.61 Billion
Earnings per Share$-1.6
Beta0.4
Outstanding Shares187,000,112

Return

Return on Equity-7.48%ROE
Return on Assets-5.25%
Return on Invested Capital-3.16%

Valuation & Multiples

P/E Ratio-43.26P/E Ratio
PEG34.23PEG
Price to Sales3.52Price to Sales
Price to Book Ratio3.52Price to Book Ratio
Enterprise Value to Revenue2.83
Enterprise Value to EBIT-84.71
Enterprise Value to Net Income-40
Total Debt to Enterprise0.08
Debt to Equity0.23Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
August 11, 2026
EPS Estimate
$0.12
Consensus analyst estimate
Revenue Estimate
$355.96 M
Consensus analyst estimate

Next Earnings Call

Expected Date
November 10, 2026
EPS Estimate
$0.01
Consensus analyst estimate
Revenue Estimate
$361.46 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.0000▼ 70.48%
Total Calls-▼ 100.00%
Total Puts-▼ 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.88%▼ 54.24%
Total Invested$33.07M▼ 98.89%
Investors Holding40▼ 190.00%

About Legend Biotech Corp

Legend Biotech Insider Information FAQ

Stockcircle tracks 5 top investors with a current 13F position in Legend Biotech. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 2 top investors increased or opened positions and 3 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 4 open-market insider sales for Legend Biotech in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.